AMX vs. VRTX
Compare and contrast key facts about América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX).
Performance
AMX vs. VRTX - Performance Comparison
Loading graphics...
AMX vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AMX América Móvil, S.A.B. de C.V. | 23.27% | 48.56% | -20.36% | 4.60% | -9.82% | 48.68% | -6.62% | 15.01% | -15.29% | 39.13% |
VRTX Vertex Pharmaceuticals Incorporated | -1.50% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | 7.94% | 32.13% | 10.58% | 103.42% |
Fundamentals
AMX:
$76.17B
VRTX:
$114.36B
AMX:
$27.54
VRTX:
$15.35
AMX:
0.93
VRTX:
29.09
AMX:
0.02
VRTX:
2.42
AMX:
0.08
VRTX:
9.58
AMX:
0.21
VRTX:
6.13
AMX:
$939.71B
VRTX:
$12.00B
AMX:
$403.52B
VRTX:
$10.35B
AMX:
$380.00B
VRTX:
$4.74B
Returns By Period
In the year-to-date period, AMX achieves a 23.27% return, which is significantly higher than VRTX's -1.50% return. Over the past 10 years, AMX has underperformed VRTX with an annualized return of 7.82%, while VRTX has yielded a comparatively higher 18.89% annualized return.
AMX
- 1D
- 3.45%
- 1M
- -2.08%
- YTD
- 23.27%
- 6M
- 22.85%
- 1Y
- 84.29%
- 3Y*
- 9.66%
- 5Y*
- 16.78%
- 10Y*
- 7.82%
VRTX
- 1D
- 0.76%
- 1M
- -10.12%
- YTD
- -1.50%
- 6M
- 14.02%
- 1Y
- -7.90%
- 3Y*
- 12.33%
- 5Y*
- 15.95%
- 10Y*
- 18.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMX vs. VRTX — Risk / Return Rank
AMX
VRTX
AMX vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for América Móvil, S.A.B. de C.V. (AMX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AMX | VRTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.06 | -0.22 | +3.28 |
Sortino ratioReturn per unit of downside risk | 4.06 | -0.05 | +4.11 |
Omega ratioGain probability vs. loss probability | 1.53 | 0.99 | +0.54 |
Calmar ratioReturn relative to maximum drawdown | 5.34 | -0.33 | +5.67 |
Martin ratioReturn relative to average drawdown | 14.74 | -0.65 | +15.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AMX | VRTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.06 | -0.22 | +3.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.66 | 0.56 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | 0.57 | -0.30 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.32 | 0.26 | +0.07 |
Correlation
The correlation between AMX and VRTX is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AMX vs. VRTX - Dividend Comparison
AMX's dividend yield for the trailing twelve months is around 2.18%, while VRTX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMX América Móvil, S.A.B. de C.V. | 2.18% | 2.68% | 3.59% | 2.83% | 4.41% | 1.88% | 2.49% | 2.29% | 2.24% | 1.91% | 2.27% | 8.55% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
AMX vs. VRTX - Drawdown Comparison
The maximum AMX drawdown since its inception was -64.34%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for AMX and VRTX.
Loading graphics...
Drawdown Indicators
| AMX | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -64.34% | -91.77% | +27.43% |
Max Drawdown (1Y)Largest decline over 1 year | -15.36% | -28.06% | +12.70% |
Max Drawdown (5Y)Largest decline over 5 years | -38.08% | -29.07% | -9.01% |
Max Drawdown (10Y)Largest decline over 10 years | -44.45% | -41.60% | -2.85% |
Current DrawdownCurrent decline from peak | -2.08% | -13.59% | +11.51% |
Average DrawdownAverage peak-to-trough decline | -24.27% | -37.81% | +13.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.56% | 14.33% | -8.77% |
Volatility
AMX vs. VRTX - Volatility Comparison
The current volatility for América Móvil, S.A.B. de C.V. (AMX) is 11.09%, while Vertex Pharmaceuticals Incorporated (VRTX) has a volatility of 11.93%. This indicates that AMX experiences smaller price fluctuations and is considered to be less risky than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AMX | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.09% | 11.93% | -0.84% |
Volatility (6M)Calculated over the trailing 6-month period | 20.46% | 21.67% | -1.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.72% | 35.83% | -8.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.66% | 28.77% | -3.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.27% | 33.24% | -3.97% |
Financials
AMX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between América Móvil, S.A.B. de C.V. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AMX vs. VRTX - Profitability Comparison
AMX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, América Móvil, S.A.B. de C.V. reported a gross profit of 102.69B and revenue of 240.97B. Therefore, the gross margin over that period was 42.6%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.72B and revenue of 3.19B. Therefore, the gross margin over that period was 85.4%.
AMX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, América Móvil, S.A.B. de C.V. reported an operating income of 50.50B and revenue of 240.97B, resulting in an operating margin of 21.0%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.26B and revenue of 3.19B, resulting in an operating margin of 39.6%.
AMX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, América Móvil, S.A.B. de C.V. reported a net income of 18.83B and revenue of 240.97B, resulting in a net margin of 7.8%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.19B and revenue of 3.19B, resulting in a net margin of 37.3%.